Agilent Technologies Inc.
A
Market Cap$41.65B
Close$
Earnings Call Q3 2024
August 21, 2024 - AI Summary
Agilent's Q3 revenue of $1.578 billion declined 4.4% on a core basis, but showed a sequential improvement of 300 basis points.
The Life Sciences and Applied Markets Group (LSAG) reported a decline of 7% in revenue, with instrument sales remaining constrained, while consumables grew by mid-single digits.
The Agilent CrossLab Group (ACG) delivered solid revenue growth of mid-single digits, driven by double-digit growth in service contracts and a record operating margin of 34%.
Exclusive for Stockcircle Pro members
Sign up
$107.18
26.1% downside
Current Fair Value
26.1% downsideOvervalued by 26.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $41.65 Billion |
|---|---|
| Enterprise Value | $43.33 Billion |
| Dividend Yield | $0.94 (0.6511692074222251%) |
| Earnings per Share | $4.22 |
| Beta | 1.06 |
| Outstanding Shares | 290,000,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 29.75 |
|---|---|
| PEG | 19.31 |
| Price to Sales | 6.59 |
| Price to Book Ratio | 7.25 |
| Enterprise Value to Revenue | 6.67 |
| Enterprise Value to EBIT | 28.17 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Agilent Technologies Inc.
CEO: Michael McMullen